Bizarre Patents
Mouse device with a built-in printer
A mouse device for use as an input device of a computer is provided that includes a housing in which recording paper is loadable, and a printer unit provided within the housing for printing on the recording paper print information received from the computer.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7825095 | Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics A patient suffering from an endobronchial infection is treated by administering to the patient for inhalation a dose of less than about 4.0 ml of a nebulized aerosol formulation comprising from about 60 to about 200 mg/ml of an aminoglycoside antibiotic, such as tob... | 11/02/2010 |
| 7371733 | Anti bacterial compounds The invention relates to novel paranmycin compounds that have activity against gram positive and gram negative bacteria, preferably bacteria that are resistant to other antibiotics. Paranmycins are of the general formula ... | 05/13/2008 |
| 7345024 | Pharmaceutical preparation, method for its production as well as its use The invention relates to hardly soluble antiphlogistic salts and antiphlogistic-antibiotic pharmaceutical preparations and their use. The hardly water soluble antiphlogistic antibiotics salts have as their cationic component one of the antibiotics gentamicin, clinda... | 03/18/2008 |
| 7267828 | Light stabilized antimicrobial materials Methods of enhancing the photostabilizing of silver in medical materials are described. More particularly, the methods increase the photostabilization of silver in certain materials comprising hydrophilic, amphoteric and anionic polymers by subjecting the polymers t... | 09/11/2007 |
| 7128897 | Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis Pharmaceutical compositions are described that contain one agent for treatment of sinusitis and a surfactant. The compositions are prepared to have a surface tension that renders the composition effective for treatment of sinusitis. ... | 10/31/2006 |
| 6890907 | Methods and unit dose formulations for the inhalation administration of tobramycin A patient suffering from an endobronchial infection is treated by administering to the patient for inhalation a dose of less than about 4.0 ml of a nebulized aerosol formulation comprising from about 60 to about 200 mg/ml of an aminoglycoside antibiotic, such as tob... | 05/10/2005 |
| 6858589 | Methods of and compositions for potentiating the action of agents active on cell wall sites of the susceptible bacteria The invention provides a method of potentiating the activity of antibacterial agents that act on bacterial cell walls, comprising the step of administering to a subject an antibacterial agent and an aminoglycoside to attain a peak concentration of at least 4 mg/l of... | 02/22/2005 |
| 6818625 | Method for increasing survival rate of cells in animal cell culture under hypoxia condition The present invention relates to a method for increasing survival rate of cells in animal cell culture under hypoxia condition by adding antibiotics to the culture media. The method of present invention comprises a step of culturing animal cells in culture media con... | 11/16/2004 |
| 6716822 | Therapeutic agent for ischemia which inhibits apoptosis under ischemic condition The present invention relates to a therapeutic agent for ischemia which inhibits apoptosis under ischemic condition. The therapeutic agent of the present invention comprises antibacterial agents of quinolones, quinones, aminoglycosides or chloramphenicol as an activ... | 04/06/2004 |
| 6620782 | Substituted 2-aminobenzamide caspase inhibitors and the use thereof The present invention is directed to novel 2-aminobenzamide thereof, represented by the general Formula I: ##STR1## where R1 -R3, X, and A--D are defined herein. The present invention also relates to the discovery that compounds havi... | 09/16/2003 |
| 6613743 | Sulfonamide inhibitors of aspartyl protease The present invention relates to a novel class of sulfonamides of formula I which are aspartyl protease inhibitors. In one embodiment, this invention relates to a novel class of HIV aspartyl protease inhibitors characterized by specific structural and phy... | 09/02/2003 |
| 6541456 | Antimicrobial 2-deoxystreptamine compounds The present invention is directed to analogs of aminoglycoside compounds of the class having a glycosylated 2-deoxystreptamine (2-DOS) ring as well as their preparation and use as prophylactic or therapeutics against microbial infection. Compounds of the ... | 04/01/2003 |
| 6541507 | Indolecarboxylic compounds for inducing/stimulating hair growth and/or retarding hair loss Indolecarboxylic acid compounds and derivatives thereof, notably 4,6-dimethoxyindole-2-carboxylic acid and derivatives thereof, are especially useful for inducing/stimulating mammalian hair growth and/or preventing/retarding mammalian hair loss.... | 04/01/2003 |
| 6528490 | Oenothein medicaments The invention provides medicaments comprising an oenothein, including topical formulations for use as free radical scavengers, or to treat irritation, or to treat inflammation. The oenothein for use in such formulations, such as oenothein-A or oenothein-B... | 03/04/2003 |
| 6475992 | Methods of and compositions for potentiating the action of agents active on cell wall sites of the susceptible bacteria The invention provides a method of potentiating the activity of antibacterial agents that act on bacterial cell walls, comprising the step of administering to a subject an antibacterial agent and an aminoglycoside to attain a peak concentration of at leas... | 11/05/2002 |
| 6475993 | Treatment of hereditary diseases with gentamicin This invention relates to a method of treating an inherited disease due to a point mutation producing a stop codon by administering an effective dose of an aminoglycoside antibiotic or a derivative thereof. Mdx mouse, which is an animal model for Duchenne... | 11/05/2002 |
| 6379882 | Method for selecting compounds for treating ischemia-related cellular damage A method of screening for and treating subjects with a therapeutically effective amount of a compound that is effective in reducing cellular damage related to an ischemic condition, such as stroke or glaucoma. Test compounds are selected and therapeutical... | 04/30/2002 |
| 6083922 | Method and a tobramycin aerosol formulation for treatment prevention and containment of tuberculosis A method for treatment, prevention and containment of acute and chronic tuberculosis using a preservative-free concentrated tobramycin aerosol formulation delivering tobramycin to the lung endobronchial space including alveoli in an aerosol having mass me... | 07/04/2000 |
| 6037140 | Selective media for the culture and isolation of gram bacteria, antibiotic composition This invention relates to a selective medium for the culture and isolation of Gram- bacteria comprising at least one antibiotic specifically active against Gram+ bacteria and at least one bacteriocin.... | 03/14/2000 |
| 5900406 | Use of antibiotics of the type 2-deoxystreptamine substituted with aminosugars to inhibit growth of microorganisms containing group I introns The invention described herein provides for methods of screening for compounds that can be used to prevent or inhibit the growth of microbial eukaryotes, particularly plant or animal pathogens. The screening methods of the invention involve the step of sc... | 05/04/1999 |
| 5843911 | Hyaluronidase inhibitor containing god-type ellagitannin as active ingredient Hyaluronidase inhibitor containing GOD-type ellagitannin as an active ingredient, as well as pharmaceuticals and cosmetics containing the inhibitor. The activity of hyaluronidase which hydrolyses hyaluronic acid can be inhibited without causing any toxici... | 12/01/1998 |
| 5677288 | Use of aminoglycosides to protect against excitotoxic neuron damage A method is disclosed for reducing excitotoxic damage to neurons, which can occur as a result of stroke, cardiac arrest, or other events or conditions. This method involves administering an aminoglycoside that suppresses the flow of calcium ions into neur... | 10/14/1997 |
| 5663152 | Potentiators for aminoglycosides The present invention provides antimicrobial compositions, especially compositions comprising an antimicrobial (microbiocidal or microbiostatic) compound and a potentiator of antimicrobial activity. Compositions of the invention combinating an antimicrobi... | 09/02/1997 |
| 5662929 | Therapeutic liposomal formulation The invention relates to a liposomal formulation containing a therapeutic agent. The formulation of the invention when administered to animals, allows a substantial increase in antibacterial activity of the agent, through an enhanced penetration of the ag... | 09/02/1997 |
| 5595977 | Salts of amino glycosides The present invention relates to novel amino glycoside salts of sucrose-octa-O-sulfonic acid of formula I: ([sucrose-octa-O-sulfonic acid8- ]-[R-(NH3+)x ]y -Mzn+) ... | 01/21/1997 |
| 5571821 | Sulfonamides and derivatives thereof that modulate the activity of endothelin Sulfonamides and methods using these sulfonamides for inhibiting the binding of an endothelin peptide to an endothelin receptor by contacting the receptor with the sulfonamide are provided. Methods for treating endothelin-mediated disorders by administeri... | 11/05/1996 |
| 5508269 | Aminoglycoside formulation for aerosolization An aminoglycoside formulation for delivery by aerosolization. The concentrated aminoglycoside formulation containing an efficacious amount of aminoglycoside able to inhibit 95-100% of susceptible bacteria. Aminoglycoside formulated in 5 ml solution of a q... | 04/16/1996 |
| 5470836 | Paromomycin or its derivatives or salts thereof in combination with sodium stirogluconate for parenteral treatment of human parasitic diseases A compound of formula (I): ##STR1## wherein: R1 is a hydroxy group or an amino group optionally substituted with a C1 -C4 alkyl or phenyl-(C1 -C4) alkyl group, R2 is hydrogen or a hydr... | 11/28/1995 |
| 4877775 | Polymeric aminosaccharides as antihypercholesterolemic agents Crosslinked copolymers of monomeric aminosaccharides such as aminoglycosidic antibiotics, e.g. neomycin, or of polymeric aminosaccharides, e.g., chitosan, with dialdehydes are useful antihypercholesterolemic agents due to their ability to bind with bile ... | 10/31/1989 |
| 4749694 | Novel lysine esters used as absorption Novel lysine esters used as absorption enhancing agents for gastrointestinally and rectally administered drugs. Also provided are processes for preparation of said lysine ester compounds as well as pharmaceutical formulations and methods for their use as ... | 06/07/1988 |
| 4650790 | Drug combinations having synergistic effect The invention relates to a synergistic antibiotic composition useful for the treatment of respiratory, gastrointestinal or urinary infections and septicaemia of domestic animals. The composition comprises tiamulin hydrogen fumarate and an aminoglycoside a... | 03/17/1987 |
| 4612337 | Method for preparing infection-resistant materials An infection-resistant polymeric material, such as polytetrafluoroethylene, for use on or within a human or animal body, for example, in the form of a vascular graft, can be prepared by an improved method which comprises the following sequence of steps: (... | 09/16/1986 |
| 4505901 | Compositions and methods for topical treatment of cutaneous leishmaniasis with paromomycin The compositions contain a mixture of paromomycin or a non-toxic acid addition salt thereof and dimethylsulfoxide or a quaternary ammonium salt having topical anti-infective activity, together with an inert carrier. There is also provided a method for the... | 03/19/1985 |
| 4478822 | Drug delivery system utilizing thermosetting gels This invention relates to a unique drug delivery system for delivering drugs to a body cavity. The drug delivery system comprises a medicament and a polymer such that the drug delivery system is a liquid at room temperature but forms a semi-solid or gel a... | 10/23/1984 |
| 4474753 | Topical drug delivery system utilizing thermosetting gels This invention relates to a unique drug delivery system for application to the skin which drug delivery system is a liquid at room temperature, but when administered topically to the skin becomes a semi-solid or gel when warmed by the body.... | 10/02/1984 |
| 4407792 | Sustained release ophthalmic drug dosage The present invention is directed to an aqueous dispersion of an ophthalmic drug and a high molecular weight polymer which forms a highly viscous gel and can be used to prolong the duration of activity of the ophthalmic drug when the gel is applied into t... | 10/04/1983 |
| 4351830 | Polymeric compound, MF-300, with protective activity against bacterial infections and its preparation A new polymeric compound, MF-300, is provided, which possesses a specific protective activity against bacterial infections caused particularly by Pseudomonas aeruginosa. The compound is derived from the reaction of ribostamycin with crotonoyl chloride fol... | 09/28/1982 |
| 4271143 | Sustained release ophthalmic drug dosage The present invention is directed to an aqueous dispersion of an ophthalmic drug and a high molecular weight polymer which forms a highly viscous gel and can be used to prolong the duration of activity of the ophthalmic drug when the gel is applied into t... | 06/02/1981 |
| 4170641 | 1-N-(ω-aminoalkanesulfonyl) derivative of aminoglycosidic antibiotic and process for preparation thereof A new 1-N-(ω-aminoalkanesulfonyl) derivative of an aminoglycosidic antibiotic such as ribostamycin, 3'-deoxy- or 3',4'-dideoxy-ribostamycin, kanamycin A or B, and 3'-deoxy- or 3',4'-dideoxy-kanamycin B exhibits a broader, antibacterial spectrum than the ... | 10/09/1979 |
| 4170643 | Aminoglycoside-aminocyclitol derivatives and method of use Novel aminoglycoside-aminocyclitol derivatives corresponding to the general formula: ##STR1## wherein R1 and R2, which are different, represent hydrogen or CH2 NH2 and R is selected from the group consistin... | 10/09/1979 |
